Diagnostic value of sputum cultures in children under 2 years of age with chronic suppurative lung diseases
Background Acquiring sputum cultures from infants is considered challenging. We describe their yield in infants with cystic fibrosis (CF) and other chronic suppurative lung diseases (CSLDs). Methods Retrospective medical record review over a 4‐year period, for infants aged 0–2 years with ≥2 airway b...
Gespeichert in:
Veröffentlicht in: | Pediatric pulmonology 2020-12, Vol.55 (12), p.3421-3428 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3428 |
---|---|
container_issue | 12 |
container_start_page | 3421 |
container_title | Pediatric pulmonology |
container_volume | 55 |
creator | Stafler, Patrick Zaks‐Hoffer, Gal Scheuerman, Oded Ben‐Zvi, Haim Mussaffi, Huda Mei‐Zahav, Meir Steuer, Guy Levine, Hagit Bar‐On, Ophir Mantin, Hadas Prais, Dario Blau, Hannah |
description | Background
Acquiring sputum cultures from infants is considered challenging. We describe their yield in infants with cystic fibrosis (CF) and other chronic suppurative lung diseases (CSLDs).
Methods
Retrospective medical record review over a 4‐year period, for infants aged 0–2 years with ≥2 airway bacterial cultures acquired by deep suction or induced sputum ≥4 weeks apart. Data included demographics, culture results, and clinical status.
Results
A total of 98 infants (16 CF) were evaluated and 534 sputum cultures acquired, 201 in CF and 333 in CSLD. There were 12 (2–23), median (range) cultures/CF infant, and 3 (2–21)/CSLD infant. Age at first culture was 3.8 (1–19.5) months for CF and 10.4 (0.5–22) months for CSLD; p = .016. In total, 360 cultures (67%) were positive for any bacteria, with 170/234 (73%) positive during exacerbations, compared with 190/300 (63%) during routine visits; p = .05. More infants with CF than CSLD had cultures positive for Staphylococcus aureus (SA; 75% vs. 34%; p = .004) throughout the period. Pseudomonas aeruginosa (PA) was common in both CF and CSLD (56% and 44%, respectively; p = .42) and increased over time for CF but was high throughout for CSLD. The number of hospital days before PA acquisition was 6 (10.2) for CF and 28.8 (38.7) for CSLD (p = .003). No CF but 6/82 (7%) CSLD infants had chronic PA (p = .56).
Conclusions
Sputum cultures showed that infection, in particular PA, is common in CF and CSLD whereas SA is more common in CF. Prospective studies are warranted to elucidate the role of active surveillance in guiding antibiotic therapy. |
doi_str_mv | 10.1002/ppul.25103 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2448410680</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2458504380</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3573-4c763b043a8aa31ccca97d956f12708d809f0ecae3bac34b6e9e580aa39a65c93</originalsourceid><addsrcrecordid>eNp90UFP2zAYBmBrAo3CdtkPmCxxmSYFPsexYx-nsjGkSnCg58h1vhQzN8nsGNR_j0u7HThw8uF79OqVX0K-MLhgAOXlOCZ_UQoG_AOZMdC6gErLIzJTtRCFVJKfkNMYHwHyTbOP5IRzAFlymJE_V86s-yFOztIn4xPSoaNxTFPaUJv8lAJG6npqH5xvA_Y09S0GWtItmhB32KyRPrvpIZMw9DkmplwomMk9IfWpX9PWRTQR4ydy3Bkf8fPhPSPLXz_v57-Lxe31zfzHorBc1LyobC35CipulDGcWWuNrlstZMfKGlSrQHeA1iBfGcurlUSNQkG22khhNT8j3_a5Yxj-JoxTs3HRovemxyHFpqwqVTGQCjI9f0MfhxT63C4roURu8aq-75UNQ4wBu2YMbmPCtmHQ7CZodhM0rxNk_PUQmVYbbP_Tf3-eAduDZ-dx-05Uc3e3XOxDXwBUGpIf</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2458504380</pqid></control><display><type>article</type><title>Diagnostic value of sputum cultures in children under 2 years of age with chronic suppurative lung diseases</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Stafler, Patrick ; Zaks‐Hoffer, Gal ; Scheuerman, Oded ; Ben‐Zvi, Haim ; Mussaffi, Huda ; Mei‐Zahav, Meir ; Steuer, Guy ; Levine, Hagit ; Bar‐On, Ophir ; Mantin, Hadas ; Prais, Dario ; Blau, Hannah</creator><creatorcontrib>Stafler, Patrick ; Zaks‐Hoffer, Gal ; Scheuerman, Oded ; Ben‐Zvi, Haim ; Mussaffi, Huda ; Mei‐Zahav, Meir ; Steuer, Guy ; Levine, Hagit ; Bar‐On, Ophir ; Mantin, Hadas ; Prais, Dario ; Blau, Hannah</creatorcontrib><description>Background
Acquiring sputum cultures from infants is considered challenging. We describe their yield in infants with cystic fibrosis (CF) and other chronic suppurative lung diseases (CSLDs).
Methods
Retrospective medical record review over a 4‐year period, for infants aged 0–2 years with ≥2 airway bacterial cultures acquired by deep suction or induced sputum ≥4 weeks apart. Data included demographics, culture results, and clinical status.
Results
A total of 98 infants (16 CF) were evaluated and 534 sputum cultures acquired, 201 in CF and 333 in CSLD. There were 12 (2–23), median (range) cultures/CF infant, and 3 (2–21)/CSLD infant. Age at first culture was 3.8 (1–19.5) months for CF and 10.4 (0.5–22) months for CSLD; p = .016. In total, 360 cultures (67%) were positive for any bacteria, with 170/234 (73%) positive during exacerbations, compared with 190/300 (63%) during routine visits; p = .05. More infants with CF than CSLD had cultures positive for Staphylococcus aureus (SA; 75% vs. 34%; p = .004) throughout the period. Pseudomonas aeruginosa (PA) was common in both CF and CSLD (56% and 44%, respectively; p = .42) and increased over time for CF but was high throughout for CSLD. The number of hospital days before PA acquisition was 6 (10.2) for CF and 28.8 (38.7) for CSLD (p = .003). No CF but 6/82 (7%) CSLD infants had chronic PA (p = .56).
Conclusions
Sputum cultures showed that infection, in particular PA, is common in CF and CSLD whereas SA is more common in CF. Prospective studies are warranted to elucidate the role of active surveillance in guiding antibiotic therapy.</description><identifier>ISSN: 8755-6863</identifier><identifier>EISSN: 1099-0496</identifier><identifier>DOI: 10.1002/ppul.25103</identifier><identifier>PMID: 33006230</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>airway infection ; Anti-Bacterial Agents - therapeutic use ; Bacteria ; Child ; Child, Preschool ; chronic suppurative lung disease ; Cystic fibrosis ; Cystic Fibrosis - drug therapy ; deep suction ; Female ; Humans ; induced sputum ; Infant ; Infant, Newborn ; Lung diseases ; Lung Diseases - diagnosis ; Lung Diseases - microbiology ; Male ; Prospective Studies ; Pseudomonas aeruginosa ; Retrospective Studies ; Sputum - microbiology ; Suppuration - drug therapy</subject><ispartof>Pediatric pulmonology, 2020-12, Vol.55 (12), p.3421-3428</ispartof><rights>2020 Wiley Periodicals LLC</rights><rights>2020 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3573-4c763b043a8aa31ccca97d956f12708d809f0ecae3bac34b6e9e580aa39a65c93</citedby><cites>FETCH-LOGICAL-c3573-4c763b043a8aa31ccca97d956f12708d809f0ecae3bac34b6e9e580aa39a65c93</cites><orcidid>0000-0001-8880-8212 ; 0000-0002-6683-0264</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fppul.25103$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fppul.25103$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33006230$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stafler, Patrick</creatorcontrib><creatorcontrib>Zaks‐Hoffer, Gal</creatorcontrib><creatorcontrib>Scheuerman, Oded</creatorcontrib><creatorcontrib>Ben‐Zvi, Haim</creatorcontrib><creatorcontrib>Mussaffi, Huda</creatorcontrib><creatorcontrib>Mei‐Zahav, Meir</creatorcontrib><creatorcontrib>Steuer, Guy</creatorcontrib><creatorcontrib>Levine, Hagit</creatorcontrib><creatorcontrib>Bar‐On, Ophir</creatorcontrib><creatorcontrib>Mantin, Hadas</creatorcontrib><creatorcontrib>Prais, Dario</creatorcontrib><creatorcontrib>Blau, Hannah</creatorcontrib><title>Diagnostic value of sputum cultures in children under 2 years of age with chronic suppurative lung diseases</title><title>Pediatric pulmonology</title><addtitle>Pediatr Pulmonol</addtitle><description>Background
Acquiring sputum cultures from infants is considered challenging. We describe their yield in infants with cystic fibrosis (CF) and other chronic suppurative lung diseases (CSLDs).
Methods
Retrospective medical record review over a 4‐year period, for infants aged 0–2 years with ≥2 airway bacterial cultures acquired by deep suction or induced sputum ≥4 weeks apart. Data included demographics, culture results, and clinical status.
Results
A total of 98 infants (16 CF) were evaluated and 534 sputum cultures acquired, 201 in CF and 333 in CSLD. There were 12 (2–23), median (range) cultures/CF infant, and 3 (2–21)/CSLD infant. Age at first culture was 3.8 (1–19.5) months for CF and 10.4 (0.5–22) months for CSLD; p = .016. In total, 360 cultures (67%) were positive for any bacteria, with 170/234 (73%) positive during exacerbations, compared with 190/300 (63%) during routine visits; p = .05. More infants with CF than CSLD had cultures positive for Staphylococcus aureus (SA; 75% vs. 34%; p = .004) throughout the period. Pseudomonas aeruginosa (PA) was common in both CF and CSLD (56% and 44%, respectively; p = .42) and increased over time for CF but was high throughout for CSLD. The number of hospital days before PA acquisition was 6 (10.2) for CF and 28.8 (38.7) for CSLD (p = .003). No CF but 6/82 (7%) CSLD infants had chronic PA (p = .56).
Conclusions
Sputum cultures showed that infection, in particular PA, is common in CF and CSLD whereas SA is more common in CF. Prospective studies are warranted to elucidate the role of active surveillance in guiding antibiotic therapy.</description><subject>airway infection</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Bacteria</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>chronic suppurative lung disease</subject><subject>Cystic fibrosis</subject><subject>Cystic Fibrosis - drug therapy</subject><subject>deep suction</subject><subject>Female</subject><subject>Humans</subject><subject>induced sputum</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Lung diseases</subject><subject>Lung Diseases - diagnosis</subject><subject>Lung Diseases - microbiology</subject><subject>Male</subject><subject>Prospective Studies</subject><subject>Pseudomonas aeruginosa</subject><subject>Retrospective Studies</subject><subject>Sputum - microbiology</subject><subject>Suppuration - drug therapy</subject><issn>8755-6863</issn><issn>1099-0496</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90UFP2zAYBmBrAo3CdtkPmCxxmSYFPsexYx-nsjGkSnCg58h1vhQzN8nsGNR_j0u7HThw8uF79OqVX0K-MLhgAOXlOCZ_UQoG_AOZMdC6gErLIzJTtRCFVJKfkNMYHwHyTbOP5IRzAFlymJE_V86s-yFOztIn4xPSoaNxTFPaUJv8lAJG6npqH5xvA_Y09S0GWtItmhB32KyRPrvpIZMw9DkmplwomMk9IfWpX9PWRTQR4ydy3Bkf8fPhPSPLXz_v57-Lxe31zfzHorBc1LyobC35CipulDGcWWuNrlstZMfKGlSrQHeA1iBfGcurlUSNQkG22khhNT8j3_a5Yxj-JoxTs3HRovemxyHFpqwqVTGQCjI9f0MfhxT63C4roURu8aq-75UNQ4wBu2YMbmPCtmHQ7CZodhM0rxNk_PUQmVYbbP_Tf3-eAduDZ-dx-05Uc3e3XOxDXwBUGpIf</recordid><startdate>202012</startdate><enddate>202012</enddate><creator>Stafler, Patrick</creator><creator>Zaks‐Hoffer, Gal</creator><creator>Scheuerman, Oded</creator><creator>Ben‐Zvi, Haim</creator><creator>Mussaffi, Huda</creator><creator>Mei‐Zahav, Meir</creator><creator>Steuer, Guy</creator><creator>Levine, Hagit</creator><creator>Bar‐On, Ophir</creator><creator>Mantin, Hadas</creator><creator>Prais, Dario</creator><creator>Blau, Hannah</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8880-8212</orcidid><orcidid>https://orcid.org/0000-0002-6683-0264</orcidid></search><sort><creationdate>202012</creationdate><title>Diagnostic value of sputum cultures in children under 2 years of age with chronic suppurative lung diseases</title><author>Stafler, Patrick ; Zaks‐Hoffer, Gal ; Scheuerman, Oded ; Ben‐Zvi, Haim ; Mussaffi, Huda ; Mei‐Zahav, Meir ; Steuer, Guy ; Levine, Hagit ; Bar‐On, Ophir ; Mantin, Hadas ; Prais, Dario ; Blau, Hannah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3573-4c763b043a8aa31ccca97d956f12708d809f0ecae3bac34b6e9e580aa39a65c93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>airway infection</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Bacteria</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>chronic suppurative lung disease</topic><topic>Cystic fibrosis</topic><topic>Cystic Fibrosis - drug therapy</topic><topic>deep suction</topic><topic>Female</topic><topic>Humans</topic><topic>induced sputum</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Lung diseases</topic><topic>Lung Diseases - diagnosis</topic><topic>Lung Diseases - microbiology</topic><topic>Male</topic><topic>Prospective Studies</topic><topic>Pseudomonas aeruginosa</topic><topic>Retrospective Studies</topic><topic>Sputum - microbiology</topic><topic>Suppuration - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stafler, Patrick</creatorcontrib><creatorcontrib>Zaks‐Hoffer, Gal</creatorcontrib><creatorcontrib>Scheuerman, Oded</creatorcontrib><creatorcontrib>Ben‐Zvi, Haim</creatorcontrib><creatorcontrib>Mussaffi, Huda</creatorcontrib><creatorcontrib>Mei‐Zahav, Meir</creatorcontrib><creatorcontrib>Steuer, Guy</creatorcontrib><creatorcontrib>Levine, Hagit</creatorcontrib><creatorcontrib>Bar‐On, Ophir</creatorcontrib><creatorcontrib>Mantin, Hadas</creatorcontrib><creatorcontrib>Prais, Dario</creatorcontrib><creatorcontrib>Blau, Hannah</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric pulmonology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stafler, Patrick</au><au>Zaks‐Hoffer, Gal</au><au>Scheuerman, Oded</au><au>Ben‐Zvi, Haim</au><au>Mussaffi, Huda</au><au>Mei‐Zahav, Meir</au><au>Steuer, Guy</au><au>Levine, Hagit</au><au>Bar‐On, Ophir</au><au>Mantin, Hadas</au><au>Prais, Dario</au><au>Blau, Hannah</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diagnostic value of sputum cultures in children under 2 years of age with chronic suppurative lung diseases</atitle><jtitle>Pediatric pulmonology</jtitle><addtitle>Pediatr Pulmonol</addtitle><date>2020-12</date><risdate>2020</risdate><volume>55</volume><issue>12</issue><spage>3421</spage><epage>3428</epage><pages>3421-3428</pages><issn>8755-6863</issn><eissn>1099-0496</eissn><abstract>Background
Acquiring sputum cultures from infants is considered challenging. We describe their yield in infants with cystic fibrosis (CF) and other chronic suppurative lung diseases (CSLDs).
Methods
Retrospective medical record review over a 4‐year period, for infants aged 0–2 years with ≥2 airway bacterial cultures acquired by deep suction or induced sputum ≥4 weeks apart. Data included demographics, culture results, and clinical status.
Results
A total of 98 infants (16 CF) were evaluated and 534 sputum cultures acquired, 201 in CF and 333 in CSLD. There were 12 (2–23), median (range) cultures/CF infant, and 3 (2–21)/CSLD infant. Age at first culture was 3.8 (1–19.5) months for CF and 10.4 (0.5–22) months for CSLD; p = .016. In total, 360 cultures (67%) were positive for any bacteria, with 170/234 (73%) positive during exacerbations, compared with 190/300 (63%) during routine visits; p = .05. More infants with CF than CSLD had cultures positive for Staphylococcus aureus (SA; 75% vs. 34%; p = .004) throughout the period. Pseudomonas aeruginosa (PA) was common in both CF and CSLD (56% and 44%, respectively; p = .42) and increased over time for CF but was high throughout for CSLD. The number of hospital days before PA acquisition was 6 (10.2) for CF and 28.8 (38.7) for CSLD (p = .003). No CF but 6/82 (7%) CSLD infants had chronic PA (p = .56).
Conclusions
Sputum cultures showed that infection, in particular PA, is common in CF and CSLD whereas SA is more common in CF. Prospective studies are warranted to elucidate the role of active surveillance in guiding antibiotic therapy.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>33006230</pmid><doi>10.1002/ppul.25103</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-8880-8212</orcidid><orcidid>https://orcid.org/0000-0002-6683-0264</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 8755-6863 |
ispartof | Pediatric pulmonology, 2020-12, Vol.55 (12), p.3421-3428 |
issn | 8755-6863 1099-0496 |
language | eng |
recordid | cdi_proquest_miscellaneous_2448410680 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | airway infection Anti-Bacterial Agents - therapeutic use Bacteria Child Child, Preschool chronic suppurative lung disease Cystic fibrosis Cystic Fibrosis - drug therapy deep suction Female Humans induced sputum Infant Infant, Newborn Lung diseases Lung Diseases - diagnosis Lung Diseases - microbiology Male Prospective Studies Pseudomonas aeruginosa Retrospective Studies Sputum - microbiology Suppuration - drug therapy |
title | Diagnostic value of sputum cultures in children under 2 years of age with chronic suppurative lung diseases |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T17%3A22%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diagnostic%20value%20of%20sputum%20cultures%20in%20children%20under%202%20years%20of%20age%20with%20chronic%20suppurative%20lung%20diseases&rft.jtitle=Pediatric%20pulmonology&rft.au=Stafler,%20Patrick&rft.date=2020-12&rft.volume=55&rft.issue=12&rft.spage=3421&rft.epage=3428&rft.pages=3421-3428&rft.issn=8755-6863&rft.eissn=1099-0496&rft_id=info:doi/10.1002/ppul.25103&rft_dat=%3Cproquest_cross%3E2458504380%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2458504380&rft_id=info:pmid/33006230&rfr_iscdi=true |